YDL223C (HBT1) umenzi we-powder CAS No.: 489408-02-8 99% ubumsulwa min. zokongeza izithako
Ividiyo yeMveliso
IiParameters zeMveliso
Igama lemveliso | HBT1 |
Elinye igama | YDL223C |
Inombolo yeCAS. | 489408-02-8 |
Ifomula yemolekyuli | I-C16H17F3N4O2S |
Ubunzima bemolekyuli | 386.40 |
Ubunyulu | 99.0% |
Imbonakalo | Ukukhanya okuqinileyo okutyheli |
Ukupakisha | 1kg kwingxowa nganye 25kg igubu ngalinye |
Isicelo | nootropics |
Intshayelelo yemveliso
I-HBT1 ibophelela kwi-domain ye-ligand-binding ye-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPA-R) ngendlela exhomekeke kwi-glutamate. Oku kuthetha ukuba i-HBT1 yimolekyuli enokuthi ibophe kuphela kwindawo ethile kwiprotheni ye-AMPA-R xa i-glutamate ikhona, kwaye oku kubopha kunceda ukulawula umsebenzi weprotheni. Ama-receptors e-AMPA abonakaliswa kuyo yonke inkqubo ye-nervous central kwaye adlale indima ebalulekileyo kunxibelelwano lwe-neuronal, ukusetyenzwa kweenzwa, ukufunda, imemori, kunye ne-synaptic plasticity. I-AMPA i-receptors inegalelo elikhulu kwi-neurotransmission evuselelayo, i-mediate ngokukhawuleza, ngokukhawuleza yenza ukuba i-synapses ikhuphe ngokukhawuleza, kwaye ibandakanyeka kwiimpendulo zakwangoko kwi-glutamate kwimimandla ye-synaptic. Ama-receptors e-AMPA ahlala edityaniswa kunye ne-NMDA receptors kwii-synapses, kwaye kunye zikhuthaza iinkqubo zeplastiki ze-synaptic ezibandakanyeka ekufundeni, imemori, i-excitotoxicity, kunye ne-neuroprotection. I-brain-derived neurotrophic factor (BDNF) i-neurotrophic factor edlala indima ebalulekileyo ekugcinweni nasekukhuliseni i-neurons kwaye ineempembelelo ezinamandla kunye neninzi ekwandeni, ukwahlula, ukusinda kunye nokufa kweeseli ze-neuronal kunye ne-non-neuronal. , imodyuli ye-neurotransmitter enegalelo kwi-neuronal plasticity ekufundeni nakwimemori. Ngoko ke, kubalulekile kwimpilo kunye nokuphila kakuhle kwenkqubo ye-nervous.
Uphawu
(1) Ukucoceka okuphezulu: I-HBT1 inokufumana iimveliso ezicocekileyo ngokucokisa iinkqubo zokuvelisa. Ukucoceka okuphezulu kuthetha ukuba ngcono kwe-bioavailability kunye neempendulo ezimbalwa ezimbi.
(2) Ukhuseleko: I-HBT1 ibonakaliswe ukuba ikhuselekile kumzimba womntu.
(3) Ukuzinza: I-HBT1 inozinzo oluhle kwaye inokugcina umsebenzi wayo kunye nesiphumo phantsi kweemeko ezahlukeneyo kunye neemeko zokugcina.
Usetyenziso
I-HBT1 yinoveli ye-AMPA receptor enhancer ene-agonism ephantsi, eyenza ukuveliswa kwe-brain-derived neurotrophic factor (BDNF) kwaye ineziphumo ezincinci ze-agonistic kwii-neurons eziphambili. I-HBT1 ibophelela kwi-ligand-binding domain ye-AMPA-R ngendlela exhomekeke kwi-glutamate. Ngokudibeneyo, bakhuthaza iinkqubo zeplastiki ze-synaptic ezibandakanyekayo ekufundeni, kwimemori, e-excitability, kunye ne-neuroprotection. Inokuphucula amandla okuqonda kunye nenkumbulo yengqondo, kwaye iphucule isakhono sokufunda sabantu. Ngokuqhelekileyo yongezwa kwisondlo semihla ngemihla ngendlela yezongezo zokutya.